Statistics
Publications
6
Citations
116
H-Index
6
Active since
2014
Ke Cao is an author at Nanjing University of Chinese Medicine specializing in pharmacology, medicine, and oncology.
Publications per year
2014–2021
6
6
Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases.
Qinghai Zeng, Cuihong Jin, Wenhang Chen et al. · PubMed · 2014 · 34 citations
Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice
Li Wu, Ke Cao, Zi Hui Ni et al. · Journal of Ethnopharmacology · 2018 · 26 citations · Full text
Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells
Li Wu, Xiao Liu, Ke Cao et al. · Journal of Cellular Biochemistry · 2018 · 20 citations
Medicine, Oncology, Pharmacology +17
1–5 of 6